Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $17.42M.
ENTERPRISE VALUE (EV)
$17.42M
Optimi Health Corp.
Market Cap
$13.56M
Enterprise Value (EV)
$17.42M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Optimi Health Corp. (OPTH) | $13.56M | $17.42M |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | $5.85M |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.77M | $3.94M |
| IN8bio, Inc. (INAB)vs › | $13.89M | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $13.01M | $6.39M |
| Passage Bio, Inc. (PASG)vs › | $12.88M | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | $11.31M |
| Cytosorbents Corporation (CTSO)vs › | $12.60M | $34.52M |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.51M | N/A |
Market Cap
$13.56M
Total Debt
$4.69M
Cash
$819724.80
Enterprise Value
$17.42M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
